[go: up one dir, main page]

NO931400L - Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav - Google Patents

Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav

Info

Publication number
NO931400L
NO931400L NO93931400A NO931400A NO931400L NO 931400 L NO931400 L NO 931400L NO 93931400 A NO93931400 A NO 93931400A NO 931400 A NO931400 A NO 931400A NO 931400 L NO931400 L NO 931400L
Authority
NO
Norway
Prior art keywords
derivatives
agif
adipogenese
preparation
inhibitor factor
Prior art date
Application number
NO93931400A
Other languages
English (en)
Other versions
NO931400D0 (no
Inventor
Kenjii Miyadai
Ichiro Kawashima
Jun Ohsumi
Yo Takiguchi
Yasuhiro Ito
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO931400D0 publication Critical patent/NO931400D0/no
Publication of NO931400L publication Critical patent/NO931400L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5431—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører derivater av adipogenese-inhiberende faktor (AGIF) som er ekvivalente til modent AGIF som mangler fra 2 til 9 av de N-terminale aminosyrer, så vel som nukleinsyre som koder for slike derivater, vektorer og vertsceller som inneholder slik nukleinsyre, og produksjonsmetoder for derivater. Opp- finnelsen vedrører også anvendelsen av AGIF-derivater som er ekvivalente til modent AGIF som mangler fra l til 9 av de N-terminale aminosyrer som terapeutiske virkemidler mot cytopeni og fettsyke.
NO93931400A 1992-04-17 1993-04-16 Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav NO931400L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9756792 1992-04-17
JP1405693 1993-01-29

Publications (2)

Publication Number Publication Date
NO931400D0 NO931400D0 (no) 1993-04-16
NO931400L true NO931400L (no) 1993-10-18

Family

ID=26349942

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931400A NO931400L (no) 1992-04-17 1993-04-16 Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav

Country Status (11)

Country Link
EP (1) EP0566410A3 (no)
KR (1) KR940005798A (no)
CN (1) CN1082112A (no)
AU (1) AU3695293A (no)
CA (1) CA2094177A1 (no)
CZ (1) CZ65893A3 (no)
FI (1) FI931701A7 (no)
HU (1) HUT66598A (no)
IL (1) IL105406A (no)
NO (1) NO931400L (no)
NZ (1) NZ247419A (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124439A (en) * 1994-08-17 2000-09-26 The Rockefeller University OB polypeptide antibodies and method of making
RU2273645C9 (ru) * 1994-08-17 2006-11-27 Дзе Рокефеллер Юниверсити Полипептид ожирения (ов)(варианты), его аналог (варианты) и слитый белок (варианты), изолированная молекула нуклеиновой кислоты, молекула днк, рекомбинантный вектор клонирования, рекомбинантный вектор экспрессии, фармацевтическая композиция, моноклональное и поликлональное антитело
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6001968A (en) * 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6048837A (en) * 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
US6124448A (en) * 1994-08-17 2000-09-26 The Rockfeller University Nucleic acid primers and probes for the mammalian OB gene
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5827734A (en) * 1995-01-20 1998-10-27 University Of Washington Materials and methods for determining ob protein in a biological sample
US5858967A (en) * 1995-01-20 1999-01-12 University Of Washington Appetite supression factor and related methods
WO1996023515A1 (en) * 1995-01-31 1996-08-08 Eli Lilly And Company Anti-obesity proteins
AU5800696A (en) * 1995-05-26 1996-12-11 Eli Lilly And Company Rhesus ob protein and dna

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2752819B2 (ja) * 1990-11-08 1998-05-18 三共株式会社 新規サイトカイン
US5270181A (en) 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules

Also Published As

Publication number Publication date
AU3695293A (en) 1993-10-21
NZ247419A (en) 1994-10-26
CZ65893A3 (en) 1993-12-15
FI931701A0 (fi) 1993-04-15
HU9301116D0 (en) 1993-07-28
HUT66598A (en) 1994-12-28
IL105406A0 (en) 1993-08-18
CN1082112A (zh) 1994-02-16
KR940005798A (ko) 1994-03-22
FI931701L (fi) 1993-10-18
CA2094177A1 (en) 1993-10-18
EP0566410A2 (en) 1993-10-20
IL105406A (en) 2000-01-31
EP0566410A3 (en) 1994-08-24
FI931701A7 (fi) 1993-10-18
NO931400D0 (no) 1993-04-16

Similar Documents

Publication Publication Date Title
NO931400L (no) Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav
NO20092860L (no) 2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
HUP0000492A1 (hu) N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
DE3482589D1 (de) Retro-inverse analoga des bradykinin-potentialisierenden peptids bpp-5a und verfahren zu ihrer herstellung.
HUP0100284A2 (hu) Aktivált protein C készítmények
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
IL129409A0 (en) 1-Phenylpyrazole compounds and pharmaceutical compositions containing the same
IL104154A0 (en) Saccharin derivatives,their preparation and pharmaceutical compositions containing them
GR3002605T3 (en) Pharmaceutical compositions containing a derivative of 3-hydroxy-butanoic acid chosen among oligomers of this acid and among esters of this acid or of these oligomers with 1,3-butane-diol
DK254787A (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
BG104266A (en) Aminoterminally incised mcp-2 as haemokin antagonists
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
HUT51298A (en) Process for producing retarde hirudine derivatives and pharmaceutical compositions containing them as active components
NO304515B1 (no) FremgangsmÕte for fremstilling av <beta>-fenylisoserin og analoger derav samt mellomprodukt
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ES2001863A6 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos que contienen un atomo de carbono tetrasubstituido, inhibidores de la renina y de las proteasas acidas
EP0257312A3 (en) A new cartilage-derived leukocyte elastase-inhibitor
DK0561877T3 (da) Forbindelser og præparater der hæmmer knogleresorption
DE69104220D1 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
NO306395B1 (no) Tilidindihydrogenortofosfat, fremgangsmaate for dets fremstilling og farmasöytiske preparater inneholdende forbindelsen samt anvendelser derav
HUT52117A (en) Process for producing amblyommin and process for producing pharmaceutical compositions comprising such compound as active ingredient